[Italian multicenter study for the verification of the efficacy and tolerability of short-term substitution hormone therapy using conjugated estrogens and progestagens administered orally in the postmenopausal a period].
Three hundred and sixty-three postmenopausal women received 6 months of cyclic hormone replacement therapy with conjugated estrogens in differing doses (0.625 mg and 1.25 mg) associated in a sequential pattern lasting 12 days with progestagens (medroxyprogesterone acetate or medrogestone) in 16 italian health centres. The results of the multicentre study confirm the efficacy of this conjugated estrogen-progestogen regimen in resolving climacteric syndrome, offering cardiovascular protection and vaginal trophic effect and preventing postmenopausal osteoporosis, as well as confirming its tolerability in relation to blood pressure, body weight, breast, endometrium, blood coagulation and hepato-renal function.
De Aloysio
D
D
Centro per lo Studio della Fisiopatologia del Climaterio, Università degli Studi di Bologna.
Mauloni
M
M
Altieri
P
P
Cappi
G P
GP
Monterubbianesi
M
M
Bottiglioni
F
F
D000284:Administration, Oral; D004305:Dose-Response Relationship, Drug; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007558:Italy; D008524:Medrogestone / Q000008:administration & dosage; D008525:Medroxyprogesterone / Q000008:administration & dosage; D008875:Middle Aged
D004967:Estrogens; D008524:Medrogestone; D008525:Medroxyprogesterone
Studio multicentrico italiano di verifica in merito all'efficacia ed alla tollerabilità della terapia ormonale sostitutiva a breve termine con estrogeni coniugati e progestinici per via orale nella postmenopausa.